Global Neisseria meningitidis Infections Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Neisseria meningitidis Infections Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Neisseria meningitidis Infections Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Neisseria meningitidis Infections Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While MGBBP-3 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Neisseria meningitidis Infections Drug include Beijing Minhai Biotechnology Co Ltd, Biological E Ltd, China National Pharmaceutical Group Corp, GlaxoSmithKline Plc, and Griffith University, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Neisseria meningitidis Infections Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Neisseria meningitidis Infections Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neisseria meningitidis Infections Drug, with price, sales, revenue and global market share of Neisseria meningitidis Infections Drug from 2019 to 2022.
Chapter 3, the Neisseria meningitidis Infections Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neisseria meningitidis Infections Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Neisseria meningitidis Infections Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neisseria meningitidis Infections Drug.
Chapter 13, 14, and 15, to describe Neisseria meningitidis Infections Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Neisseria meningitidis Infections Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Neisseria meningitidis Infections Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While MGBBP-3 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Neisseria meningitidis Infections Drug include Beijing Minhai Biotechnology Co Ltd, Biological E Ltd, China National Pharmaceutical Group Corp, GlaxoSmithKline Plc, and Griffith University, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Neisseria meningitidis Infections Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- MGBBP-3
- NCL-195
- TP-10
- Others
- Hospital
- Clinic
- Others
- Beijing Minhai Biotechnology Co Ltd
- Biological E Ltd
- China National Pharmaceutical Group Corp
- GlaxoSmithKline Plc
- Griffith University
- ImmunoBiology Ltd
- JN-International Medical Corp
- MGB Biopharma Ltd
- Panacea Biotec Ltd
- Pfizer Inc
- Sanofi Pasteur SA
- Serum Institute of India Ltd
- Wellstat Vaccines LLC
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Neisseria meningitidis Infections Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neisseria meningitidis Infections Drug, with price, sales, revenue and global market share of Neisseria meningitidis Infections Drug from 2019 to 2022.
Chapter 3, the Neisseria meningitidis Infections Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neisseria meningitidis Infections Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Neisseria meningitidis Infections Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neisseria meningitidis Infections Drug.
Chapter 13, 14, and 15, to describe Neisseria meningitidis Infections Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Neisseria meningitidis Infections Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neisseria meningitidis Infections Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 MGBBP-3
1.2.3 NCL-195
1.2.4 TP-10
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Neisseria meningitidis Infections Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Neisseria meningitidis Infections Drug Market Size & Forecast
1.4.1 Global Neisseria meningitidis Infections Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Neisseria meningitidis Infections Drug Sales in Volume (2017-2028)
1.4.3 Global Neisseria meningitidis Infections Drug Price (2017-2028)
1.5 Global Neisseria meningitidis Infections Drug Production Capacity Analysis
1.5.1 Global Neisseria meningitidis Infections Drug Total Production Capacity (2017-2028)
1.5.2 Global Neisseria meningitidis Infections Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neisseria meningitidis Infections Drug Market Drivers
1.6.2 Neisseria meningitidis Infections Drug Market Restraints
1.6.3 Neisseria meningitidis Infections Drug Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Beijing Minhai Biotechnology Co Ltd
2.1.1 Beijing Minhai Biotechnology Co Ltd Details
2.1.2 Beijing Minhai Biotechnology Co Ltd Major Business
2.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product and Services
2.1.4 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Biological E Ltd
2.2.1 Biological E Ltd Details
2.2.2 Biological E Ltd Major Business
2.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Product and Services
2.2.4 Biological E Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 China National Pharmaceutical Group Corp
2.3.1 China National Pharmaceutical Group Corp Details
2.3.2 China National Pharmaceutical Group Corp Major Business
2.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product and Services
2.3.4 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 GlaxoSmithKline Plc
2.4.1 GlaxoSmithKline Plc Details
2.4.2 GlaxoSmithKline Plc Major Business
2.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product and Services
2.4.4 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Griffith University
2.5.1 Griffith University Details
2.5.2 Griffith University Major Business
2.5.3 Griffith University Neisseria meningitidis Infections Drug Product and Services
2.5.4 Griffith University Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 ImmunoBiology Ltd
2.6.1 ImmunoBiology Ltd Details
2.6.2 ImmunoBiology Ltd Major Business
2.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product and Services
2.6.4 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 JN-International Medical Corp
2.7.1 JN-International Medical Corp Details
2.7.2 JN-International Medical Corp Major Business
2.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Product and Services
2.7.4 JN-International Medical Corp Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 MGB Biopharma Ltd
2.8.1 MGB Biopharma Ltd Details
2.8.2 MGB Biopharma Ltd Major Business
2.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product and Services
2.8.4 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Panacea Biotec Ltd
2.9.1 Panacea Biotec Ltd Details
2.9.2 Panacea Biotec Ltd Major Business
2.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product and Services
2.9.4 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Pfizer Inc
2.10.1 Pfizer Inc Details
2.10.2 Pfizer Inc Major Business
2.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Product and Services
2.10.4 Pfizer Inc Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Sanofi Pasteur SA
2.11.1 Sanofi Pasteur SA Details
2.11.2 Sanofi Pasteur SA Major Business
2.11.3 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product and Services
2.11.4 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Serum Institute of India Ltd
2.12.1 Serum Institute of India Ltd Details
2.12.2 Serum Institute of India Ltd Major Business
2.12.3 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product and Services
2.12.4 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Wellstat Vaccines LLC
2.13.1 Wellstat Vaccines LLC Details
2.13.2 Wellstat Vaccines LLC Major Business
2.13.3 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product and Services
2.13.4 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 NEISSERIA MENINGITIDIS INFECTIONS DRUG BREAKDOWN DATA BY MANUFACTURER
3.1 Global Neisseria meningitidis Infections Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Neisseria meningitidis Infections Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Neisseria meningitidis Infections Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Neisseria meningitidis Infections Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Neisseria meningitidis Infections Drug Manufacturer Market Share in 2021
3.5 Global Neisseria meningitidis Infections Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Neisseria meningitidis Infections Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Neisseria meningitidis Infections Drug Market Size by Region
4.1.1 Global Neisseria meningitidis Infections Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Neisseria meningitidis Infections Drug Revenue by Region (2017-2028)
4.2 North America Neisseria meningitidis Infections Drug Revenue (2017-2028)
4.3 Europe Neisseria meningitidis Infections Drug Revenue (2017-2028)
4.4 Asia-Pacific Neisseria meningitidis Infections Drug Revenue (2017-2028)
4.5 South America Neisseria meningitidis Infections Drug Revenue (2017-2028)
4.6 Middle East and Africa Neisseria meningitidis Infections Drug Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Neisseria meningitidis Infections Drug Sales in Volume by Type (2017-2028)
5.2 Global Neisseria meningitidis Infections Drug Revenue by Type (2017-2028)
5.3 Global Neisseria meningitidis Infections Drug Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Neisseria meningitidis Infections Drug Sales in Volume by Application (2017-2028)
6.2 Global Neisseria meningitidis Infections Drug Revenue by Application (2017-2028)
6.3 Global Neisseria meningitidis Infections Drug Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Neisseria meningitidis Infections Drug Sales by Type (2017-2028)
7.2 North America Neisseria meningitidis Infections Drug Sales by Application (2017-2028)
7.3 North America Neisseria meningitidis Infections Drug Market Size by Country
7.3.1 North America Neisseria meningitidis Infections Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Neisseria meningitidis Infections Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Neisseria meningitidis Infections Drug Sales by Type (2017-2028)
8.2 Europe Neisseria meningitidis Infections Drug Sales by Application (2017-2028)
8.3 Europe Neisseria meningitidis Infections Drug Market Size by Country
8.3.1 Europe Neisseria meningitidis Infections Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Neisseria meningitidis Infections Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Neisseria meningitidis Infections Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Neisseria meningitidis Infections Drug Market Size by Region
9.3.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Neisseria meningitidis Infections Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Neisseria meningitidis Infections Drug Sales by Type (2017-2028)
10.2 South America Neisseria meningitidis Infections Drug Sales by Application (2017-2028)
10.3 South America Neisseria meningitidis Infections Drug Market Size by Country
10.3.1 South America Neisseria meningitidis Infections Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Neisseria meningitidis Infections Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Neisseria meningitidis Infections Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Neisseria meningitidis Infections Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Neisseria meningitidis Infections Drug Market Size by Country
11.3.1 Middle East & Africa Neisseria meningitidis Infections Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Neisseria meningitidis Infections Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Neisseria meningitidis Infections Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Neisseria meningitidis Infections Drug
12.3 Neisseria meningitidis Infections Drug Production Process
12.4 Neisseria meningitidis Infections Drug Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Neisseria meningitidis Infections Drug Typical Distributors
13.3 Neisseria meningitidis Infections Drug Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 Neisseria meningitidis Infections Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neisseria meningitidis Infections Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 MGBBP-3
1.2.3 NCL-195
1.2.4 TP-10
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Neisseria meningitidis Infections Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Neisseria meningitidis Infections Drug Market Size & Forecast
1.4.1 Global Neisseria meningitidis Infections Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Neisseria meningitidis Infections Drug Sales in Volume (2017-2028)
1.4.3 Global Neisseria meningitidis Infections Drug Price (2017-2028)
1.5 Global Neisseria meningitidis Infections Drug Production Capacity Analysis
1.5.1 Global Neisseria meningitidis Infections Drug Total Production Capacity (2017-2028)
1.5.2 Global Neisseria meningitidis Infections Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neisseria meningitidis Infections Drug Market Drivers
1.6.2 Neisseria meningitidis Infections Drug Market Restraints
1.6.3 Neisseria meningitidis Infections Drug Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Beijing Minhai Biotechnology Co Ltd
2.1.1 Beijing Minhai Biotechnology Co Ltd Details
2.1.2 Beijing Minhai Biotechnology Co Ltd Major Business
2.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product and Services
2.1.4 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Biological E Ltd
2.2.1 Biological E Ltd Details
2.2.2 Biological E Ltd Major Business
2.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Product and Services
2.2.4 Biological E Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 China National Pharmaceutical Group Corp
2.3.1 China National Pharmaceutical Group Corp Details
2.3.2 China National Pharmaceutical Group Corp Major Business
2.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product and Services
2.3.4 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 GlaxoSmithKline Plc
2.4.1 GlaxoSmithKline Plc Details
2.4.2 GlaxoSmithKline Plc Major Business
2.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product and Services
2.4.4 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Griffith University
2.5.1 Griffith University Details
2.5.2 Griffith University Major Business
2.5.3 Griffith University Neisseria meningitidis Infections Drug Product and Services
2.5.4 Griffith University Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 ImmunoBiology Ltd
2.6.1 ImmunoBiology Ltd Details
2.6.2 ImmunoBiology Ltd Major Business
2.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product and Services
2.6.4 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 JN-International Medical Corp
2.7.1 JN-International Medical Corp Details
2.7.2 JN-International Medical Corp Major Business
2.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Product and Services
2.7.4 JN-International Medical Corp Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 MGB Biopharma Ltd
2.8.1 MGB Biopharma Ltd Details
2.8.2 MGB Biopharma Ltd Major Business
2.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product and Services
2.8.4 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Panacea Biotec Ltd
2.9.1 Panacea Biotec Ltd Details
2.9.2 Panacea Biotec Ltd Major Business
2.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product and Services
2.9.4 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Pfizer Inc
2.10.1 Pfizer Inc Details
2.10.2 Pfizer Inc Major Business
2.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Product and Services
2.10.4 Pfizer Inc Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Sanofi Pasteur SA
2.11.1 Sanofi Pasteur SA Details
2.11.2 Sanofi Pasteur SA Major Business
2.11.3 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product and Services
2.11.4 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Serum Institute of India Ltd
2.12.1 Serum Institute of India Ltd Details
2.12.2 Serum Institute of India Ltd Major Business
2.12.3 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product and Services
2.12.4 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Wellstat Vaccines LLC
2.13.1 Wellstat Vaccines LLC Details
2.13.2 Wellstat Vaccines LLC Major Business
2.13.3 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product and Services
2.13.4 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 NEISSERIA MENINGITIDIS INFECTIONS DRUG BREAKDOWN DATA BY MANUFACTURER
3.1 Global Neisseria meningitidis Infections Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Neisseria meningitidis Infections Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Neisseria meningitidis Infections Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Neisseria meningitidis Infections Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Neisseria meningitidis Infections Drug Manufacturer Market Share in 2021
3.5 Global Neisseria meningitidis Infections Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Neisseria meningitidis Infections Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Neisseria meningitidis Infections Drug Market Size by Region
4.1.1 Global Neisseria meningitidis Infections Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Neisseria meningitidis Infections Drug Revenue by Region (2017-2028)
4.2 North America Neisseria meningitidis Infections Drug Revenue (2017-2028)
4.3 Europe Neisseria meningitidis Infections Drug Revenue (2017-2028)
4.4 Asia-Pacific Neisseria meningitidis Infections Drug Revenue (2017-2028)
4.5 South America Neisseria meningitidis Infections Drug Revenue (2017-2028)
4.6 Middle East and Africa Neisseria meningitidis Infections Drug Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Neisseria meningitidis Infections Drug Sales in Volume by Type (2017-2028)
5.2 Global Neisseria meningitidis Infections Drug Revenue by Type (2017-2028)
5.3 Global Neisseria meningitidis Infections Drug Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Neisseria meningitidis Infections Drug Sales in Volume by Application (2017-2028)
6.2 Global Neisseria meningitidis Infections Drug Revenue by Application (2017-2028)
6.3 Global Neisseria meningitidis Infections Drug Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Neisseria meningitidis Infections Drug Sales by Type (2017-2028)
7.2 North America Neisseria meningitidis Infections Drug Sales by Application (2017-2028)
7.3 North America Neisseria meningitidis Infections Drug Market Size by Country
7.3.1 North America Neisseria meningitidis Infections Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Neisseria meningitidis Infections Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Neisseria meningitidis Infections Drug Sales by Type (2017-2028)
8.2 Europe Neisseria meningitidis Infections Drug Sales by Application (2017-2028)
8.3 Europe Neisseria meningitidis Infections Drug Market Size by Country
8.3.1 Europe Neisseria meningitidis Infections Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Neisseria meningitidis Infections Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Neisseria meningitidis Infections Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Neisseria meningitidis Infections Drug Market Size by Region
9.3.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Neisseria meningitidis Infections Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Neisseria meningitidis Infections Drug Sales by Type (2017-2028)
10.2 South America Neisseria meningitidis Infections Drug Sales by Application (2017-2028)
10.3 South America Neisseria meningitidis Infections Drug Market Size by Country
10.3.1 South America Neisseria meningitidis Infections Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Neisseria meningitidis Infections Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Neisseria meningitidis Infections Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Neisseria meningitidis Infections Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Neisseria meningitidis Infections Drug Market Size by Country
11.3.1 Middle East & Africa Neisseria meningitidis Infections Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Neisseria meningitidis Infections Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Neisseria meningitidis Infections Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Neisseria meningitidis Infections Drug
12.3 Neisseria meningitidis Infections Drug Production Process
12.4 Neisseria meningitidis Infections Drug Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Neisseria meningitidis Infections Drug Typical Distributors
13.3 Neisseria meningitidis Infections Drug Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Neisseria meningitidis Infections Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Neisseria meningitidis Infections Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Beijing Minhai Biotechnology Co Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Beijing Minhai Biotechnology Co Ltd Major Business
Table 5. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product and Services
Table 6. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Biological E Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Biological E Ltd Major Business
Table 9. Biological E Ltd Neisseria meningitidis Infections Drug Product and Services
Table 10. Biological E Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. China National Pharmaceutical Group Corp Basic Information, Manufacturing Base and Competitors
Table 12. China National Pharmaceutical Group Corp Major Business
Table 13. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product and Services
Table 14. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 16. GlaxoSmithKline Plc Major Business
Table 17. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product and Services
Table 18. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Griffith University Basic Information, Manufacturing Base and Competitors
Table 20. Griffith University Major Business
Table 21. Griffith University Neisseria meningitidis Infections Drug Product and Services
Table 22. Griffith University Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. ImmunoBiology Ltd Basic Information, Manufacturing Base and Competitors
Table 24. ImmunoBiology Ltd Major Business
Table 25. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product and Services
Table 26. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. JN-International Medical Corp Basic Information, Manufacturing Base and Competitors
Table 28. JN-International Medical Corp Major Business
Table 29. JN-International Medical Corp Neisseria meningitidis Infections Drug Product and Services
Table 30. JN-International Medical Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. MGB Biopharma Ltd Basic Information, Manufacturing Base and Competitors
Table 32. MGB Biopharma Ltd Major Business
Table 33. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product and Services
Table 34. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 36. Panacea Biotec Ltd Major Business
Table 37. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product and Services
Table 38. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Inc Major Business
Table 41. Pfizer Inc Neisseria meningitidis Infections Drug Product and Services
Table 42. Pfizer Inc Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Sanofi Pasteur SA Basic Information, Manufacturing Base and Competitors
Table 44. Sanofi Pasteur SA Major Business
Table 45. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product and Services
Table 46. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Serum Institute of India Ltd Basic Information, Manufacturing Base and Competitors
Table 48. Serum Institute of India Ltd Major Business
Table 49. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product and Services
Table 50. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Wellstat Vaccines LLC Basic Information, Manufacturing Base and Competitors
Table 52. Wellstat Vaccines LLC Major Business
Table 53. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product and Services
Table 54. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Neisseria meningitidis Infections Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 56. Global Neisseria meningitidis Infections Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Neisseria meningitidis Infections Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Neisseria meningitidis Infections Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 59. Head Office and Neisseria meningitidis Infections Drug Production Site of Key Manufacturer
Table 60. Neisseria meningitidis Infections Drug New Entrant and Capacity Expansion Plans
Table 61. Neisseria meningitidis Infections Drug Mergers & Acquisitions in the Past Five Years
Table 62. Global Neisseria meningitidis Infections Drug Sales by Region (2017-2022) & (K Pcs)
Table 63. Global Neisseria meningitidis Infections Drug Sales by Region (2023-2028) & (K Pcs)
Table 64. Global Neisseria meningitidis Infections Drug Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Neisseria meningitidis Infections Drug Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 67. Global Neisseria meningitidis Infections Drug Sales by Type (2023-2028) & (K Pcs)
Table 68. Global Neisseria meningitidis Infections Drug Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Neisseria meningitidis Infections Drug Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Neisseria meningitidis Infections Drug Price by Type (2017-2022) & (USD/Pcs)
Table 71. Global Neisseria meningitidis Infections Drug Price by Type (2023-2028) & (USD/Pcs)
Table 72. Global Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 73. Global Neisseria meningitidis Infections Drug Sales by Application (2023-2028) & (K Pcs)
Table 74. Global Neisseria meningitidis Infections Drug Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Neisseria meningitidis Infections Drug Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Neisseria meningitidis Infections Drug Price by Application (2017-2022) & (USD/Pcs)
Table 77. Global Neisseria meningitidis Infections Drug Price by Application (2023-2028) & (USD/Pcs)
Table 78. North America Neisseria meningitidis Infections Drug Sales by Country (2017-2022) & (K Pcs)
Table 79. North America Neisseria meningitidis Infections Drug Sales by Country (2023-2028) & (K Pcs)
Table 80. North America Neisseria meningitidis Infections Drug Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Neisseria meningitidis Infections Drug Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 83. North America Neisseria meningitidis Infections Drug Sales by Type (2023-2028) & (K Pcs)
Table 84. North America Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 85. North America Neisseria meningitidis Infections Drug Sales by Application (2023-2028) & (K Pcs)
Table 86. Europe Neisseria meningitidis Infections Drug Sales by Country (2017-2022) & (K Pcs)
Table 87. Europe Neisseria meningitidis Infections Drug Sales by Country (2023-2028) & (K Pcs)
Table 88. Europe Neisseria meningitidis Infections Drug Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Neisseria meningitidis Infections Drug Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 91. Europe Neisseria meningitidis Infections Drug Sales by Type (2023-2028) & (K Pcs)
Table 92. Europe Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 93. Europe Neisseria meningitidis Infections Drug Sales by Application (2023-2028) & (K Pcs)
Table 94. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Region (2017-2022) & (K Pcs)
Table 95. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Region (2023-2028) & (K Pcs)
Table 96. Asia-Pacific Neisseria meningitidis Infections Drug Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Neisseria meningitidis Infections Drug Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 99. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Type (2023-2028) & (K Pcs)
Table 100. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 101. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Application (2023-2028) & (K Pcs)
Table 102. South America Neisseria meningitidis Infections Drug Sales by Country (2017-2022) & (K Pcs)
Table 103. South America Neisseria meningitidis Infections Drug Sales by Country (2023-2028) & (K Pcs)
Table 104. South America Neisseria meningitidis Infections Drug Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Neisseria meningitidis Infections Drug Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 107. South America Neisseria meningitidis Infections Drug Sales by Type (2023-2028) & (K Pcs)
Table 108. South America Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 109. South America Neisseria meningitidis Infections Drug Sales by Application (2023-2028) & (K Pcs)
Table 110. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Region (2017-2022) & (K Pcs)
Table 111. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Region (2023-2028) & (K Pcs)
Table 112. Middle East & Africa Neisseria meningitidis Infections Drug Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Neisseria meningitidis Infections Drug Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 115. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Type (2023-2028) & (K Pcs)
Table 116. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 117. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Application (2023-2028) & (K Pcs)
Table 118. Neisseria meningitidis Infections Drug Raw Material
Table 119. Key Manufacturers of Neisseria meningitidis Infections Drug Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Neisseria meningitidis Infections Drug Typical Distributors
Table 123. Neisseria meningitidis Infections Drug Typical Customers
Table 1. Global Neisseria meningitidis Infections Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Neisseria meningitidis Infections Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Beijing Minhai Biotechnology Co Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Beijing Minhai Biotechnology Co Ltd Major Business
Table 5. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product and Services
Table 6. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Biological E Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Biological E Ltd Major Business
Table 9. Biological E Ltd Neisseria meningitidis Infections Drug Product and Services
Table 10. Biological E Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. China National Pharmaceutical Group Corp Basic Information, Manufacturing Base and Competitors
Table 12. China National Pharmaceutical Group Corp Major Business
Table 13. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product and Services
Table 14. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 16. GlaxoSmithKline Plc Major Business
Table 17. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product and Services
Table 18. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Griffith University Basic Information, Manufacturing Base and Competitors
Table 20. Griffith University Major Business
Table 21. Griffith University Neisseria meningitidis Infections Drug Product and Services
Table 22. Griffith University Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. ImmunoBiology Ltd Basic Information, Manufacturing Base and Competitors
Table 24. ImmunoBiology Ltd Major Business
Table 25. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product and Services
Table 26. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. JN-International Medical Corp Basic Information, Manufacturing Base and Competitors
Table 28. JN-International Medical Corp Major Business
Table 29. JN-International Medical Corp Neisseria meningitidis Infections Drug Product and Services
Table 30. JN-International Medical Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. MGB Biopharma Ltd Basic Information, Manufacturing Base and Competitors
Table 32. MGB Biopharma Ltd Major Business
Table 33. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product and Services
Table 34. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 36. Panacea Biotec Ltd Major Business
Table 37. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product and Services
Table 38. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Inc Major Business
Table 41. Pfizer Inc Neisseria meningitidis Infections Drug Product and Services
Table 42. Pfizer Inc Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Sanofi Pasteur SA Basic Information, Manufacturing Base and Competitors
Table 44. Sanofi Pasteur SA Major Business
Table 45. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product and Services
Table 46. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Serum Institute of India Ltd Basic Information, Manufacturing Base and Competitors
Table 48. Serum Institute of India Ltd Major Business
Table 49. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product and Services
Table 50. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Wellstat Vaccines LLC Basic Information, Manufacturing Base and Competitors
Table 52. Wellstat Vaccines LLC Major Business
Table 53. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product and Services
Table 54. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Neisseria meningitidis Infections Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 56. Global Neisseria meningitidis Infections Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Neisseria meningitidis Infections Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Neisseria meningitidis Infections Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 59. Head Office and Neisseria meningitidis Infections Drug Production Site of Key Manufacturer
Table 60. Neisseria meningitidis Infections Drug New Entrant and Capacity Expansion Plans
Table 61. Neisseria meningitidis Infections Drug Mergers & Acquisitions in the Past Five Years
Table 62. Global Neisseria meningitidis Infections Drug Sales by Region (2017-2022) & (K Pcs)
Table 63. Global Neisseria meningitidis Infections Drug Sales by Region (2023-2028) & (K Pcs)
Table 64. Global Neisseria meningitidis Infections Drug Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Neisseria meningitidis Infections Drug Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 67. Global Neisseria meningitidis Infections Drug Sales by Type (2023-2028) & (K Pcs)
Table 68. Global Neisseria meningitidis Infections Drug Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Neisseria meningitidis Infections Drug Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Neisseria meningitidis Infections Drug Price by Type (2017-2022) & (USD/Pcs)
Table 71. Global Neisseria meningitidis Infections Drug Price by Type (2023-2028) & (USD/Pcs)
Table 72. Global Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 73. Global Neisseria meningitidis Infections Drug Sales by Application (2023-2028) & (K Pcs)
Table 74. Global Neisseria meningitidis Infections Drug Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Neisseria meningitidis Infections Drug Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Neisseria meningitidis Infections Drug Price by Application (2017-2022) & (USD/Pcs)
Table 77. Global Neisseria meningitidis Infections Drug Price by Application (2023-2028) & (USD/Pcs)
Table 78. North America Neisseria meningitidis Infections Drug Sales by Country (2017-2022) & (K Pcs)
Table 79. North America Neisseria meningitidis Infections Drug Sales by Country (2023-2028) & (K Pcs)
Table 80. North America Neisseria meningitidis Infections Drug Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Neisseria meningitidis Infections Drug Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 83. North America Neisseria meningitidis Infections Drug Sales by Type (2023-2028) & (K Pcs)
Table 84. North America Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 85. North America Neisseria meningitidis Infections Drug Sales by Application (2023-2028) & (K Pcs)
Table 86. Europe Neisseria meningitidis Infections Drug Sales by Country (2017-2022) & (K Pcs)
Table 87. Europe Neisseria meningitidis Infections Drug Sales by Country (2023-2028) & (K Pcs)
Table 88. Europe Neisseria meningitidis Infections Drug Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Neisseria meningitidis Infections Drug Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 91. Europe Neisseria meningitidis Infections Drug Sales by Type (2023-2028) & (K Pcs)
Table 92. Europe Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 93. Europe Neisseria meningitidis Infections Drug Sales by Application (2023-2028) & (K Pcs)
Table 94. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Region (2017-2022) & (K Pcs)
Table 95. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Region (2023-2028) & (K Pcs)
Table 96. Asia-Pacific Neisseria meningitidis Infections Drug Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Neisseria meningitidis Infections Drug Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 99. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Type (2023-2028) & (K Pcs)
Table 100. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 101. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Application (2023-2028) & (K Pcs)
Table 102. South America Neisseria meningitidis Infections Drug Sales by Country (2017-2022) & (K Pcs)
Table 103. South America Neisseria meningitidis Infections Drug Sales by Country (2023-2028) & (K Pcs)
Table 104. South America Neisseria meningitidis Infections Drug Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Neisseria meningitidis Infections Drug Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 107. South America Neisseria meningitidis Infections Drug Sales by Type (2023-2028) & (K Pcs)
Table 108. South America Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 109. South America Neisseria meningitidis Infections Drug Sales by Application (2023-2028) & (K Pcs)
Table 110. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Region (2017-2022) & (K Pcs)
Table 111. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Region (2023-2028) & (K Pcs)
Table 112. Middle East & Africa Neisseria meningitidis Infections Drug Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Neisseria meningitidis Infections Drug Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 115. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Type (2023-2028) & (K Pcs)
Table 116. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 117. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Application (2023-2028) & (K Pcs)
Table 118. Neisseria meningitidis Infections Drug Raw Material
Table 119. Key Manufacturers of Neisseria meningitidis Infections Drug Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Neisseria meningitidis Infections Drug Typical Distributors
Table 123. Neisseria meningitidis Infections Drug Typical Customers
LIST OF FIGURES
Figure 1. Neisseria meningitidis Infections Drug Picture
Figure 2. Global Neisseria meningitidis Infections Drug Revenue Market Share by Type in 2021
Figure 3. MGBBP-3
Figure 4. NCL-195
Figure 5. TP-10
Figure 6. Others
Figure 7. Global Neisseria meningitidis Infections Drug Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Neisseria meningitidis Infections Drug Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 12. Global Neisseria meningitidis Infections Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Neisseria meningitidis Infections Drug Sales (2017-2028) & (K Pcs)
Figure 14. Global Neisseria meningitidis Infections Drug Price (2017-2028) & (USD/Pcs)
Figure 15. Global Neisseria meningitidis Infections Drug Production Capacity (2017-2028) & (K Pcs)
Figure 16. Global Neisseria meningitidis Infections Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Neisseria meningitidis Infections Drug Market Drivers
Figure 18. Neisseria meningitidis Infections Drug Market Restraints
Figure 19. Neisseria meningitidis Infections Drug Market Trends
Figure 20. Global Neisseria meningitidis Infections Drug Sales Market Share by Manufacturer in 2021
Figure 21. Global Neisseria meningitidis Infections Drug Revenue Market Share by Manufacturer in 2021
Figure 22. Neisseria meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Neisseria meningitidis Infections Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Neisseria meningitidis Infections Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Neisseria meningitidis Infections Drug Sales Market Share by Region (2017-2028)
Figure 26. Global Neisseria meningitidis Infections Drug Revenue Market Share by Region (2017-2028)
Figure 27. North America Neisseria meningitidis Infections Drug Revenue (2017-2028) & (USD Million)
Figure 28. Europe Neisseria meningitidis Infections Drug Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Neisseria meningitidis Infections Drug Revenue (2017-2028) & (USD Million)
Figure 30. South America Neisseria meningitidis Infections Drug Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Neisseria meningitidis Infections Drug Revenue (2017-2028) & (USD Million)
Figure 32. Global Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Neisseria meningitidis Infections Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Neisseria meningitidis Infections Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 35. Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Neisseria meningitidis Infections Drug Revenue Market Share by Application (2017-2028)
Figure 37. Global Neisseria meningitidis Infections Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 38. North America Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Neisseria meningitidis Infections Drug Sales Market Share by Country (2017-2028)
Figure 41. North America Neisseria meningitidis Infections Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Neisseria meningitidis Infections Drug Sales Market Share by Country (2017-2028)
Figure 48. Europe Neisseria meningitidis Infections Drug Revenue Market Share by Country (2017-2028)
Figure 49. Germany Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Neisseria meningitidis Infections Drug Revenue Market Share by Region (2017-2028)
Figure 58. China Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2028)
Figure 65. South America Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2028)
Figure 66. South America Neisseria meningitidis Infections Drug Sales Market Share by Country (2017-2028)
Figure 67. South America Neisseria meningitidis Infections Drug Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Neisseria meningitidis Infections Drug Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Neisseria meningitidis Infections Drug in 2021
Figure 79. Manufacturing Process Analysis of Neisseria meningitidis Infections Drug
Figure 80. Neisseria meningitidis Infections Drug Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Neisseria meningitidis Infections Drug Picture
Figure 2. Global Neisseria meningitidis Infections Drug Revenue Market Share by Type in 2021
Figure 3. MGBBP-3
Figure 4. NCL-195
Figure 5. TP-10
Figure 6. Others
Figure 7. Global Neisseria meningitidis Infections Drug Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Neisseria meningitidis Infections Drug Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 12. Global Neisseria meningitidis Infections Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Neisseria meningitidis Infections Drug Sales (2017-2028) & (K Pcs)
Figure 14. Global Neisseria meningitidis Infections Drug Price (2017-2028) & (USD/Pcs)
Figure 15. Global Neisseria meningitidis Infections Drug Production Capacity (2017-2028) & (K Pcs)
Figure 16. Global Neisseria meningitidis Infections Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Neisseria meningitidis Infections Drug Market Drivers
Figure 18. Neisseria meningitidis Infections Drug Market Restraints
Figure 19. Neisseria meningitidis Infections Drug Market Trends
Figure 20. Global Neisseria meningitidis Infections Drug Sales Market Share by Manufacturer in 2021
Figure 21. Global Neisseria meningitidis Infections Drug Revenue Market Share by Manufacturer in 2021
Figure 22. Neisseria meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Neisseria meningitidis Infections Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Neisseria meningitidis Infections Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Neisseria meningitidis Infections Drug Sales Market Share by Region (2017-2028)
Figure 26. Global Neisseria meningitidis Infections Drug Revenue Market Share by Region (2017-2028)
Figure 27. North America Neisseria meningitidis Infections Drug Revenue (2017-2028) & (USD Million)
Figure 28. Europe Neisseria meningitidis Infections Drug Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Neisseria meningitidis Infections Drug Revenue (2017-2028) & (USD Million)
Figure 30. South America Neisseria meningitidis Infections Drug Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Neisseria meningitidis Infections Drug Revenue (2017-2028) & (USD Million)
Figure 32. Global Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Neisseria meningitidis Infections Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Neisseria meningitidis Infections Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 35. Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Neisseria meningitidis Infections Drug Revenue Market Share by Application (2017-2028)
Figure 37. Global Neisseria meningitidis Infections Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 38. North America Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Neisseria meningitidis Infections Drug Sales Market Share by Country (2017-2028)
Figure 41. North America Neisseria meningitidis Infections Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Neisseria meningitidis Infections Drug Sales Market Share by Country (2017-2028)
Figure 48. Europe Neisseria meningitidis Infections Drug Revenue Market Share by Country (2017-2028)
Figure 49. Germany Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Neisseria meningitidis Infections Drug Revenue Market Share by Region (2017-2028)
Figure 58. China Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2028)
Figure 65. South America Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2028)
Figure 66. South America Neisseria meningitidis Infections Drug Sales Market Share by Country (2017-2028)
Figure 67. South America Neisseria meningitidis Infections Drug Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Neisseria meningitidis Infections Drug Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Neisseria meningitidis Infections Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Neisseria meningitidis Infections Drug in 2021
Figure 79. Manufacturing Process Analysis of Neisseria meningitidis Infections Drug
Figure 80. Neisseria meningitidis Infections Drug Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
